LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
3.590
+0.010 (0.28%)
At close: Oct 5, 2026, 4:00 PM EDT
3.600
+0.010 (0.28%)
After-hours: Oct 5, 2026, 7:52 PM EDT
LENZ Therapeutics Employees
LENZ Therapeutics had 152 employees as of December 31, 2025. The number of employees increased by 110 or 261.90% compared to the previous year.
Employees
152
Change (1Y)
110
Growth (1Y)
261.90%
Revenue / Employee
$141,283
Profits / Employee
-$828,961
Market Cap
112.80M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 152 | 110 | 261.90% |
| Dec 31, 2024 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunic | 100 |
| Rani Therapeutics Holdings | 71 |
| Vivani Medical | 42 |
| Milestone Pharmaceuticals | 38 |
| Aardvark Therapeutics | 28 |
| Genelux | 26 |
| Unicycive Therapeutics | 22 |
| Black Diamond Therapeutics | 21 |
LENZ News
- 14 days ago - These beaten-down stocks could bounce back in January, if history is any guide - Market Watch
- 7 weeks ago - Lenz Therapeutics reports Q2 EPS ($1.02), consensus ($1.07) - TheFly
- 7 weeks ago - Lenz Therapeutics price target lowered to $10 from $20 at Citi - TheFly
- 7 weeks ago - Lenz Therapeutics price target lowered to $7 from $12 at Piper Sandler - TheFly
- 7 weeks ago - Lenz Therapeutics downgraded to Neutral from Buy at BofA - TheFly
- 7 weeks ago - LENZ Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 7 weeks ago - LENZ Therapeutics Earnings release: Q2 2026 - Filings
- 7 weeks ago - LENZ Therapeutics Quarterly report: Q2 2026 - Filings